American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Business

Colgate-Palmolive stock analysis: overvalued ahead of earnings

by admin January 30, 2025
January 30, 2025
Colgate-Palmolive stock analysis: overvalued ahead of earnings

The Colgate-Palmolive stock price remains in a deep correction as investors wait for the fourth-quarter results. CL has plunged by over 17%, bringing its market cap to about $73 billion. So, is Colgate a good stock to buy the dip in?

Colgate-Palmolive is a good value company

Colgate-Palmolive is a leading company in the consumer staples industry. The firm operates its business in two key segments: oral, personal, and home care, and pet nutrition. It is one of the biggest players in the industry, owning brands like Colgate, Sorriso, Tom’s of Maine, and Sanex. 

Colgate-Palmolive’s business has done well in the past few years as its annual revenue rose from $15.7 billion in 2019 to over $20 billion in the trailing twelve months (TTM). The net income has moved from $2.16 billion in 2021 to over $2.86 billion.

The next key catalyst for the Colgate-Palmolive stock will be its upcoming financial results, which will come out on Friday. Analysts anticipate that the company’s revenue will come in at $5 billion, a 0.78% increase from the same period a year ago.

Colgate-Palmolive’s annual revenue will come in at $20.15 billion, a 3.52% annual increase. Its 2025 revenue guidance will be $20.39 billion, a 1.27% annual increase. 

These numbers mean that Colgate’s growth has largely stalled and is underperforming other companies. As such, it has become highly overvalued, with a forward P/E ratio of 25.45, up from the sector median of 18.5. The trailing-twelve-month P/E ratio of 25.8 is also higher than the sector median of 21. 

Still, analysts are optimistic that its stock wil rebound in the future. The Colgate stock forecast is $100, up from the current $89.57. The most notable bullish analysts are RBC Capital, Stifel, and UBS. 

Read more: Colgate-Palmolive (CL): dividend king stock gets overbought

Colgate-Palmolive stock price analysis

CL stock price chart by TradingView

The weekly chart shows that the CL share price peaked at $108.25 in 2024 and has now dropped to $85.80, its lowest point in April last year. 

It has stalled at the 38.2% Fibonacci Retracement point. It has moved between the 50-week and 100-week moving averages. It is hovering at the strong pivot reverse point of the Murrey Math Lines tool.

Therefore, the Colgate-Palmolive stock price will likely drop after earnings. If this happens, the next point to watch will be the 50% retracement level at $78.20 or 12% below the current level. This is an important level since it was also the highest point in 2020, 2021, 2022, and 2023. This view will be confirmed if drops below the support at $85.80. 

On the flip side, a move above the 23.60% retracement point at $94.40 will invalidate the bearish view.

The post Colgate-Palmolive stock analysis: overvalued ahead of earnings appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
Apple Q1 earnings preview: China market share, AI strategy and other things to look out for
next post
CVS Health stock price is recovering: Feb 12 will be crucial

Related Posts

Stocks tumble again as Trump’s tariff threats push...

March 14, 2025

Nikkei 225 jumps over 3%, ending 7-day slide...

September 12, 2024

Will Trump’s tariff plans impact global steel trade?

February 10, 2025

The first Fed interest rate cut in years...

July 31, 2024

Why ‘wardrobing’ retail fraud soars in the summer

August 9, 2024

Crypto market slumps to four-month low as Mt....

March 11, 2025

Lemonade stock price is rising: technicals point to...

November 20, 2024

US stocks open lower: Dow down 240 points,...

April 12, 2025

Top 2 underperforming semiconductor stocks Jim Cramer recommends...

January 26, 2025

How Trump was ‘orange-pilled’ by three bitcoiners in...

August 28, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Interview: Strategic location gives Brazil Potash cost advantage in domestic fertiliser market, says CEO Matt Simpson

      June 1, 2025
    • Canada’s Q1 GDP expands by 2.2%, driven by exports spike ahead of potential US tariffs

      June 1, 2025
    • President Trump to host farewell for Elon Musk as DOGE leader steps away

      June 1, 2025
    • UK’s digital banks face divergent fortunes: Starling stumbles, Monzo and Revolut soars

      June 1, 2025
    • Trump wants Apple to shift iPhone production from India to the US: here’s what it means

      May 18, 2025

    Categories

    • Business (3,032)
    • Investing (2,462)
    • Latest News (1,994)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved